These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 29464897)
1. Case report of neuroleptic malignant syndrome with prolonged mental changes and severe dyskinesia. Chung YJ; Lee SJ Asia Pac Psychiatry; 2018 Mar; 10(1):. PubMed ID: 29464897 [No Abstract] [Full Text] [Related]
2. Poorly controlled EPS: risk factors for NMS. Primeau F; Fontaine R; Chouinard G Can J Psychiatry; 1987 May; 32(4):328, 331. PubMed ID: 2886211 [No Abstract] [Full Text] [Related]
10. Clozapine treatment and neuroleptic malignant syndrome. Doan RJ; Callaghan WD Can J Psychiatry; 2000 May; 45(4):394-5. PubMed ID: 10813077 [No Abstract] [Full Text] [Related]
11. Neuroleptic malignant syndrome during low dosed neuroleptic medication in first-episode psychosis: a case report. Gönner F; Baumgartner R; Schüpbach D; Merlo MC Psychopharmacology (Berl); 1999 Jun; 144(4):416-8. PubMed ID: 10435416 [TBL] [Abstract][Full Text] [Related]
12. Tardive dyskinesia and current dose of neuroleptic drugs. Kolakowska T; Williams AO; Ardern M Arch Gen Psychiatry; 1985 Sep; 42(9):925. PubMed ID: 2864034 [No Abstract] [Full Text] [Related]
13. Antipsychotic induced movement disorders. Ramesh S; Sagar R Indian J Med Sci; 2001 Sep; 55(9):483-7. PubMed ID: 11887297 [No Abstract] [Full Text] [Related]
14. [Neuroleptic malignant syndrome under amisulpride in a patient during a second acute psychotic episode]. Barrimi M; El Ghazouani F; Zaimi O; Oneib B Presse Med; 2018 Feb; 47(2):172-174. PubMed ID: 29395559 [No Abstract] [Full Text] [Related]